Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.
2 min read · 26 November 2020
The firm has held the final close on its latest secondaries vehicle, which is already 20% committed to deals involving GPs such as Thomas H Lee Partners and Clearlake Capital Group.
2 min read · 19 November 2020
Brian Mooney is one of seven high-level executives to have resigned from Greenhill’s secondaries advisory unit in recent months.
2 min read · 12 November 2020
The secondaries market is more seller-friendly than ever, allowing sponsors to push terms that surprise even seasoned pros. This is unlikely to last.
2 min read · 12 November 2020
This is the second GP-led process that HarbourVest has led on a Portobello fund, after the 2015 restructuring of 2006-vintage Fund II.
2 min read · 12 November 2020
The process carried out by Antin Infrastructure Partners gives more capital to fast-growing assets in its 2016-vintage Fund III, including three fibre companies.
2 min read · 10 November 2020
Stephen Sloan, former head of private capital advisory at Greenhill, will lead the effort alongside another senior hire.
2 min read · 06 November 2020
Strong buyer demand is allowing some GPs to drive better terms for themselves on manager-led deals, according to panellists at PEI’s Women in Private Equity Forum.
2 min read · 04 November 2020
The alternatives manager is raising the Special Opportunities fund alongside its flagship secondaries vehicle, which is targeting $3.75bn.
1 min read · 03 November 2020
